New | phs002377.v1.p1 | A Phase I/IB Study of Ipilimumab or Nivolumab in Patients With Relapsed Hema

A Phase I/IB Study of Ipilimumab or Nivolumab in Patients With Relapsed Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation ( study ... Read more

Bron:

PubMed Health Featured Reviews